Journal of Cancer Sciences
Research Article
Markers of Radiogenic Cancer vs. Tumor Progression: an Overview of Chernobyl Studies
Jargin SV*
Department of Pathology, People’s Friendship University of Russia, Russia
*Address for Correspondence: Jargin SV, Department of Pathology, People’s Friendship University of
Russia, Russia, Tel: 7-495 9516788; Email: sjargin@mail.ru
Submission: 14 June, 2021
Accepted: 30 July, 2021
Published: 03 August, 2021
Copyright: © 2021 Jargin SV. This is an open access article distributed
under the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided
the original work is properly cited.
Abstract
Differences in the histological grade of malignancies may reflect
diagnostic quality, that is, averagely earlier or later tumor detection in a
given country. Studies of Chernobyl-related renal-cell carcinoma with
a control from Spain and Colombia are discussed here in comparison
with thyroid cancer research. It is concluded that suppositions
about averagely higher grade and enhanced aggressiveness
of malignancies from the areas previously contaminated by the
Chernobyl fallout are unfounded and can lead to overtreatment.
Results of many studies of Chernobyl-related malignancies are
valuable; but conclusions should be reassessed taking into account
that some cases, classified as aggressive radiogenic cancers, were
in fact late-stage neglected malignancies. Associations of various
markers with the tumor progression can become a field for the future
research and re-interpretation of data obtained in studies comparing
malignancies from different countries. Some markers may reflect
efficiency of healthcare services.